Mingyu Wei

Mingyu Wei

Auto-generated profile, based on publicly available information

Mingyu Wei

Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, Beijing, China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2025 in Neurological Sciences
Verified
Journal Article
Closed access
PDF file
XHXianjing Hu
Xianjing Hu
MWMingyu Wei
Mingyu Wei
HZHeli Zhang
Heli Zhang
MWMingxuan Wang
Mingxuan Wang
SZSiwei Zhang
Siwei Zhang
BLBaohua Li
Baohua Li

22 November 2024 in Medicine
Verified
Journal Article
Open access
MWMingyu Wei
Mingyu Wei
XHXianjing Mns Hu
Xianjing Mns Hu
MZMin Zhu
Min Zhu
SZShuai Zhang
Shuai Zhang
ZTZhenyu Tian
Zhenyu Tian
CMCui Ming
Cui Ming
Studies have shown that uremia, renal failure and heart failure (HF) are closely related. However, whether this association reflects a causal effect is still unclear. The aim of this study was to evaluate the causal effect of uremic metabolites or toxins on HF. Mendelian randomization (MR) analysis was conducted to evaluate the causal effect of 11 uremia-related metabolites on HF risk using single-nucleotide polymorphisms (SNPs) from a genome-wide association study. A protein–protein interaction network was constructed to study the function of SNPs corresponding to HF-related factors. Univariate and multivariate MR analyses demonstrated that lipoprotein A and apolipoprotein B were positively correlated with HF. The SNPs corresponding to these key factors were related mainly to MAP kinase activity and lipid metabolic processes. Overall, we identified 2 uremia-related exposure factors (lipoprotein A and apolipoprotein B) closely related to HF, laying a theoretical foundation for the treatment of HF with renal failure or uremia.